These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Probabilistic cost-effectiveness analysis of cascade screening for familial hypercholesterolaemia using alternative diagnostic and identification strategies. Nherera L, Marks D, Minhas R, Thorogood M, Humphries SE. Heart; 2011 Jul; 97(14):1175-81. PubMed ID: 21685482 [Abstract] [Full Text] [Related]
6. Homozygous familial hypercholesterolaemia in Vietnam: Case series, genetics and cascade testing of families. Truong TH, Kim NT, Nguyen MNT, Pang J, Hooper AJ, Watts GF, Do DL. Atherosclerosis; 2018 Oct; 277():392-398. PubMed ID: 30270076 [Abstract] [Full Text] [Related]
7. Elevated lipoprotein(a), hypertension and renal insufficiency as predictors of coronary artery disease in patients with genetically confirmed heterozygous familial hypercholesterolemia. Chan DC, Pang J, Hooper AJ, Burnett JR, Bell DA, Bates TR, van Bockxmeer FM, Watts GF. Int J Cardiol; 2015 Dec 15; 201():633-8. PubMed ID: 26340131 [Abstract] [Full Text] [Related]
8. Familial hypercholesterolaemia: a model of care for Australasia. Watts GF, Sullivan DR, Poplawski N, van Bockxmeer F, Hamilton-Craig I, Clifton PM, O'Brien R, Bishop W, George P, Barter PJ, Bates T, Burnett JR, Coakley J, Davidson P, Emery J, Martin A, Farid W, Freeman L, Geelhoed E, Juniper A, Kidd A, Kostner K, Krass I, Livingston M, Maxwell S, O'Leary P, Owaimrin A, Redgrave TG, Reid N, Southwell L, Suthers G, Tonkin A, Towler S, Trent R, Familial Hypercholesterolaemia Australasia Network Consensus Group (Australian Atherosclerosis Society). Atheroscler Suppl; 2011 Oct 15; 12(2):221-63. PubMed ID: 21917530 [Abstract] [Full Text] [Related]
10. The molecular genetic basis and diagnosis of familial hypercholesterolemia in Denmark. Jensen HK. Dan Med Bull; 2002 Nov 15; 49(4):318-45. PubMed ID: 12553167 [Abstract] [Full Text] [Related]
11. Treatment Gaps in Adults With Heterozygous Familial Hypercholesterolemia in the United States: Data From the CASCADE-FH Registry. deGoma EM, Ahmad ZS, O'Brien EC, Kindt I, Shrader P, Newman CB, Pokharel Y, Baum SJ, Hemphill LC, Hudgins LC, Ahmed CD, Gidding SS, Duffy D, Neal W, Wilemon K, Roe MT, Rader DJ, Ballantyne CM, Linton MF, Duell PB, Shapiro MD, Moriarty PM, Knowles JW. Circ Cardiovasc Genet; 2016 Jun 15; 9(3):240-9. PubMed ID: 27013694 [Abstract] [Full Text] [Related]
13. Improving the detection of familial hypercholesterolaemia. Lan NSR, Martin AC, Brett T, Watts GF, Bell DA. Pathology; 2019 Feb 15; 51(2):213-221. PubMed ID: 30579649 [Abstract] [Full Text] [Related]
16. Screening for hypercholesterolaemia versus case finding for familial hypercholesterolaemia: a systematic review and cost-effectiveness analysis. Marks D, Wonderling D, Thorogood M, Lambert H, Humphries SE, Neil HA. Health Technol Assess; 2000 Feb 15; 4(29):1-123. PubMed ID: 11109029 [Abstract] [Full Text] [Related]
19. Heterozygous familial hypercholesterolaemia in a pair of identical twins: a case report and updated review. Mohd Nor NS, Al-Khateeb AM, Chua YA, Mohd Kasim NA, Mohd Nawawi H. BMC Pediatr; 2019 Apr 11; 19(1):106. PubMed ID: 30975109 [Abstract] [Full Text] [Related]